Steven E. Hall's Insider Trades & SAST Disclosures

Steven E. Hall's most recent trade in Kymera Therapeutics Inc was a trade of 20,063 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 16, 2021.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Kymera Therapeutics Inc
Steven E. Hall Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2021 20,063 20,063 - - Stock Option (Right to Buy)
Kymera Therapeutics Inc
Steven E. Hall Director 25 Aug 2020 2,511,198 0 - - Series A Convertible Preferred Stock
Kymera Therapeutics Inc
Steven E. Hall Director 25 Aug 2020 2,192,249 2,192,249 - - Common Stock
Kymera Therapeutics Inc
Steven E. Hall Director 25 Aug 2020 985,220 0 - - Series B Convertible Preferred Stock
Kymera Therapeutics Inc
Steven E. Hall Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Aug 2020 40,127 40,127 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades